0001786717-26-000002.txt : 20260617 0001786717-26-000002.hdr.sgml : 20260617 20260617100902 ACCESSION NUMBER: 0001786717-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260617 DATE AS OF CHANGE: 20260617 EFFECTIVENESS DATE: 20260617 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Qlaris Bio, Inc. CENTRAL INDEX KEY: 0001786717 ORGANIZATION NAME: EIN: 823855491 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-587687 FILM NUMBER: 261096864 BUSINESS ADDRESS: STREET 1: ONE MAIN STREET, SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 201-294-7644 MAIL ADDRESS: STREET 1: ONE MAIN STREET, SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001786717 Qlaris Bio, Inc. 770 Legacy Place 2nd Floor Dedham MA MASSACHUSETTS 02026 917-217-7007 DELAWARE CalypsoQ, LLC None Corporation true Frederic Guerard 770 Legacy Place 2nd Floor Dedham MA MASSACHUSETTS 02026 Executive Officer Director Andrew Danielson 200 First Street SW Rochester MN MINNESOTA 55905-0001 Director Adrienne Graves 770 Legacy Place 2nd Floor Dedham MA MASSACHUSETTS 02026 Director Ronald M. Hunt 156 Fifth Avenue Suite 820 New York NY NEW YORK 10010 Director Wende Hutton 2765 Sand Hill Road Menlo Park CA CALIFORNIA 94025 Director Barbara Wirostko 770 Legacy Place 2nd Floor Dedham MA MASSACHUSETTS 02026 Executive Officer Robert Warner 1020 Whittington Place Southlake TX TEXAS 76092 Director Biotechnology Decline to Disclose 06b false 2026-06-12 false true true true Convertible Promissory Notes false 0 3946659 3946659 0 false 8 0 0 0 No amounts other than ordinary course employment compensation is being paid to officers and directors. false Qlaris Bio, Inc. Frederic Guerard Frederic Guerard President and Chief Executive Officer 2026-06-16